Literature DB >> 29033043

In vivo lung perfusion rehabilitates sepsis-induced lung injury.

J Hunter Mehaffey1, Eric J Charles1, Sarah Schubert1, Morgan Salmon1, Ashish K Sharma1, Dustin Money1, Mark H Stoler2, Victor E Laubach1, Curtis G Tribble1, Mark E Roeser1, Irving L Kron3.   

Abstract

BACKGROUND: Sepsis is the leading cause of lung injury in adults and can lead to acute respiratory distress syndrome (ARDS). Using a novel technique of isolated in vivo lung perfusion (IVLP), we hypothesized that normothermic IVLP will improve oxygenation and compliance in a porcine model of sepsis-induced lung injury.
METHODS: Mature adult swine (n = 8) were administered lipopolysaccharide (LPS; 50 μg/kg over 2 hours) via the external jugular vein, followed by sternotomy and central extracorporeal membrane oxygenation (ECMO) cannulation (right atrium to ascending aorta). The left pulmonary artery (inflow) and left superior and inferior pulmonary veins (outflow) were dissected out and cannulated to deliver isolated perfusion to the left lung. After 4 hours of normothermic IVLP with Steen solution, the left lung then underwent 4 hours of reperfusion after IVLP decannulation. Airway pressures and lung-specific pulmonary vein blood gases from the right lung (LPS control) and left lung (LPS + IVLP) of the same animal were compared.
RESULTS: All animals demonstrated a significant reduction in the ratio of partial pressure of oxygen in arterial blood (PaO2)/fraction of inspired oxygen (FiO2) (P/F ratio) and total lung compliance at 2 hours after the start of LPS infusion (mean, 469 ± 19.7 mm Hg vs 222.2 ± 21.4 mm Hg; P < .0001). After reperfusion, 6 animals (75%) exhibited improved lung function, allowing for ECMO decannulation. Lung-specific oxygenation was superior in the left lung after 4 hours of reperfusion (mean, 310.5 ± 54.7 mm Hg vs 201.1 ± 21.7 mm Hg; P = .01). Similarly, total lung compliance improved after IVLP of the left lung. The lung wet weight to dry weight ratio demonstrated reduced edema in rehabilitated left lungs (mean, 6.5 ± 0.3 vs 7.5 ± 0.4; P = .04).
CONCLUSIONS: IVLP successfully rehabilitated LPS-injured lungs compared to ECMO support alone in this preclinical porcine model.
Copyright © 2017 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute lung injury; in vivo lung perfusion; lung rehabilitation

Mesh:

Year:  2017        PMID: 29033043      PMCID: PMC5744259          DOI: 10.1016/j.jtcvs.2017.08.124

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  35 in total

Review 1.  Adult respiratory distress syndrome. Pathogenesis and treatment.

Authors:  J Modig
Journal:  Acta Chir Scand       Date:  1986-04

Review 2.  Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques--non-heart-beating donor lung retrieval and ex vivo donor lung perfusion.

Authors:  Jonathan C Yeung; Marcelo Cypel; Thomas K Waddell; Dirk van Raemdonck; Shaf Keshavjee
Journal:  Thorac Surg Clin       Date:  2009-05       Impact factor: 1.750

3.  Alternative solution for ex vivo lung perfusion, experimental study on donated human lungs non-accepted for transplantation.

Authors:  Lucas Matos Fernandes; Alessandro Wasum Mariani; Israel Lopes de Medeiros; Marcos Naoyuki Samano; Luís Gustavo Abdalla; Aristides Tadeu Correia; Natália Aparecida Nepomuceno; Mauro Canzian; Paulo Manuel Pêgo-Fernandes
Journal:  Acta Cir Bras       Date:  2015-05       Impact factor: 1.388

Review 4.  Association between tidal volume size, duration of ventilation, and sedation needs in patients without acute respiratory distress syndrome: an individual patient data meta-analysis.

Authors:  Ary Serpa Neto; Fabienne D Simonis; Carmen S V Barbas; Michelle Biehl; Rogier M Determann; Jonathan Elmer; Gilberto Friedman; Ognjen Gajic; Joshua N Goldstein; Janneke Horn; Nicole P Juffermans; Rita Linko; Roselaine Pinheiro de Oliveira; Sugantha Sundar; Daniel Talmor; Esther K Wolthuis; Marcelo Gama de Abreu; Paolo Pelosi; Marcus J Schultz
Journal:  Intensive Care Med       Date:  2014-05-09       Impact factor: 17.440

5.  Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo.

Authors:  Stig Steen; Qiuming Liao; Per N Wierup; Ramunas Bolys; Leif Pierre; Trygve Sjöberg
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

Review 6.  Overview of the pathology of three widely used animal models of acute lung injury.

Authors:  H M Wang; M Bodenstein; K Markstaller
Journal:  Eur Surg Res       Date:  2008-03-19       Impact factor: 1.745

7.  Comparison of the regulations by Th2-type cytokines of the arachidonic-acid metabolic pathway in human alveolar macrophages and monocytes.

Authors:  T Endo; F Ogushi; T Kawano; S Sone
Journal:  Am J Respir Cell Mol Biol       Date:  1998-08       Impact factor: 6.914

Review 8.  Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches.

Authors:  Karen J Bosma; Ravi Taneja; James F Lewis
Journal:  Drugs       Date:  2010-07-09       Impact factor: 9.546

9.  The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.

Authors:  Matthieu Schmidt; Elie Zogheib; Hadrien Rozé; Xavier Repesse; Guillaume Lebreton; Charles-Edouard Luyt; Jean-Louis Trouillet; Nicolas Bréchot; Ania Nieszkowska; Hervé Dupont; Alexandre Ouattara; Pascal Leprince; Jean Chastre; Alain Combes
Journal:  Intensive Care Med       Date:  2013-08-02       Impact factor: 17.440

Review 10.  Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Waleed Alhazzani; Mohamed Alshahrani; Roman Jaeschke; Jean Marie Forel; Laurent Papazian; Jonathan Sevransky; Maureen O Meade
Journal:  Crit Care       Date:  2013-03-11       Impact factor: 9.097

View more
  7 in total

1.  In vivo lung perfusion as a platform for organ repair in acute respiratory distress syndrome.

Authors:  Khaled Ramadan; Lorenzo Del Sorbo; Marcelo Cypel
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

2.  Steen solution protects pulmonary microvascular endothelial cells and preserves endothelial barrier after lipopolysaccharide-induced injury.

Authors:  Huy Q Ta; Nicholas R Teman; Irving L Kron; Mark E Roeser; Victor E Laubach
Journal:  J Thorac Cardiovasc Surg       Date:  2022-04-18       Impact factor: 6.439

3.  The protective effects of C16 peptide and angiopoietin-1 compound in lipopolysaccharide-induced acute respiratory distress syndrome.

Authors:  Dingqian Wu; Xiaoxiao Fu; Yuanyuan Zhang; Qiang Li; Ligang Ye; Shu Han; Mao Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-11

4.  Two Hours of In Vivo Lung Perfusion Improves Lung Function in Sepsis-Induced Acute Respiratory Distress Syndrome.

Authors:  Matthew R Byler; Nathan S Haywood; Dustin T Money; Aimee Zhang; Jared P Beller; Eric J Charles; William Z Chancellor; Huy Q Ta; Mark H Stoler; J Hunter Mehaffey; Victor E Laubach; Irving L Kron; Mark E Roeser
Journal:  Semin Thorac Cardiovasc Surg       Date:  2021-03-11

5.  Up-regulation of TUG1 can regulate miR-494/PDK4 axis to inhibit LPS-induced acute lung injury caused by sepsis.

Authors:  Lin Yang; Li Zhao; Hui Zhang; Peili Chen
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

6.  IGF2BP2 knockdown inhibits LPS-induced pyroptosis in BEAS-2B cells by targeting caspase 4, a crucial molecule of the non-canonical pyroptosis pathway.

Authors:  Jing Wang; Xiaoli Yuan; Ning Ding
Journal:  Exp Ther Med       Date:  2021-04-08       Impact factor: 2.447

Review 7.  Isolated Lung Perfusion in the Management of Acute Respiratory Distress Syndrome.

Authors:  Nathan Haywood; Matthew R Byler; Aimee Zhang; Mark E Roeser; Irving L Kron; Victor E Laubach
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.